))
Setting Up a Robust CGT Supply Chain (Part 2)
Manage episode 435605126 series 3554424
Indhold leveret af Quick Group of Companies. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Quick Group of Companies eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Today we continue our conversation with Mike Sweeney, Global Head of Strategy for Cell & Gene Therapies and Direct to Patient products at QuickSTAT Global Life Science Logistics, on how to set up a robust CGT supply chain.
In Part 1, Mike described the explosion of cell and gene therapies registered for clinical trials – plus the hope and supply chain logistics challenges that growth provides.
In Part 2, Mike discusses the benefits of advanced planning, the role of technology, as well as cold chain and chain of custody. We began, however, with his analysis of the ongoing regulatory change globally. I asked Mike: How does QuickSTAT stay on top of it, and what type of guidance do they give?
8 episoder
Del
